{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:45:20Z","timestamp":1782492320466,"version":"3.54.5"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Autoimmune encephalitis (AE) is a multifaceted topic that encompasses various aetiologies and differential diagnoses. In certain instances, the patient\u2019s serum or CSF may not reveal the presence of specific antibodies, which can leave healthcare providers unsure about the most appropriate course of treatment. This report outlines the case of a 71 years-old male who underwent a full-size liver transplantation and was subsequently maintained on Tacrolimus for immunosuppression. The patient presented with symptoms of confusion and decreased general orientation, which worsened over time. Following a thorough diagnostic workup, the patient was diagnosed with Antibody-negative Autoimmune Encephalitis (AE). He received treatment with high-dose steroids and Tacrolimus was later changed to Mycophenolate mofetil (MMF), which ameliorated his condition. This case highlights a potential link between long-term use of calcineurin inhibitors and seronegative AE. Hence, it may be advisable to consider Antibody-negative AE (ABnAE) as a potential diagnosis in patients under chronic immunosuppression who exhibit symptoms of sudden cognitive decline.<\/jats:p>","DOI":"10.3389\/fmed.2025.1540960","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:29:22Z","timestamp":1747114162000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Possible Tacrolimus-associated seronegative Autoimmune Encephalitis presenting with subacute cognitive impairment and disorientation - case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Konstantin","family":"H\u00f6lzl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Albasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1093\/brain\/awac166","article-title":"Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes.","volume":"145","author":"Lee","year":"2022","journal-title":"Brain."},{"key":"B2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1159\/000519991","article-title":"EEG contribution to the diagnosis of antibody-negative autoimmune encephalitis: a case report.","volume":"13","author":"Mito","year":"2021","journal-title":"Case Rep Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"686009","DOI":"10.3389\/fneur.2021.686009","article-title":"Case report: the use of rituximab in antibody-negative autoimmune encephalitis.","volume":"12","author":"Park","year":"2021","journal-title":"Front Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e235777","DOI":"10.1136\/bcr-2020-235777","article-title":"Antibody-negative autoimmune encephalitis as a complication of long-term immune-suppression for liver transplantation.","volume":"13","author":"Spindel","year":"2020","journal-title":"BMJ Case Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis.","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/brain\/awac338","article-title":"Seronegative autoimmune encephalitis: exploring the unknown.","volume":"145","author":"van Steenhoven","year":"2022","journal-title":"Brain."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/ene.13975","article-title":"The cerebrospinal fluid CD4\/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.","volume":"26","author":"Chazal","year":"2019","journal-title":"Eur J Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/ane.13297","article-title":"Cerebrospinal fluid CD4+ \/CD8+ ratio in diagnosing neurosarcoidosis.","volume":"142","author":"Nordstr\u00f6m","year":"2020","journal-title":"Acta Neurol Scand."},{"key":"B9","first-page":"256","article-title":"Neurosarcoidosis","author":"Giovannoni","year":"2012"},{"key":"B10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000319032","article-title":"Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation.","volume":"64","author":"Wu","year":"2010","journal-title":"Eur Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome.","volume":"264","author":"Fischer","year":"2017","journal-title":"J Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.mayocp.2015.07.018","article-title":"Albuminocytologic dissociation in posterior reversible encephalopathy syndrome.","volume":"90","author":"Datar","year":"2015","journal-title":"Mayo Clinic Proc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1586\/14737175.2015.1126510","article-title":"Diagnosis and therapy of acute disseminated encephalomyelitis and its variants.","volume":"16","author":"Berzero","year":"2016","journal-title":"Expert Rev Neurother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1111\/bcp.15704","article-title":"Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: a retrospective cohort study.","volume":"89","author":"Um","year":"2023","journal-title":"Br J Clin Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1017\/S1355617711001573","article-title":"Construct validity of the Montreal Cognitive Assessment (MoCA).","volume":"18","author":"Freitas","year":"2012","journal-title":"J Int Neuropsychol Soc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.20344\/AMP.13793","article-title":"Antibody negative autoimmune encephalitis: a case report.","volume":"33","author":"Sequeira","year":"2021","journal-title":"Acta Med Portuguesa."},{"key":"B18","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3389\/fneur.2019.00987","article-title":"Severe anti-N-methyl-D-aspartate receptor encephalitis under immunosuppression after liver transplantation.","volume":"10","author":"Konen","year":"2019","journal-title":"Front Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/s-0030-1255218","article-title":"Neurologic complications of hematopoietic cell transplantation.","volume":"30","author":"Saiz","year":"2010","journal-title":"Semin Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1111\/ajt.15789","article-title":"Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction.","volume":"20","author":"Han","year":"2020","journal-title":"Am J Transpl."},{"key":"B21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imm.12021","article-title":"The imbalance of T helper 17\/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression.","volume":"138","author":"Kim","year":"2013","journal-title":"Immunology."},{"key":"B22","author":"Kincaid","year":"1995","journal-title":"Special lectures the role of calcineurin in immune system responses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3389\/fimmu.2018.01184","article-title":"The calcineurin inhibitor tacrolimus specifically suppresses human T follicular helper cells.","volume":"9","author":"Wallin","year":"2018","journal-title":"Front Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"911779","DOI":"10.3389\/fimmu.2022.911779","article-title":"The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with the severity of autoimmune encephalitis.","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1540960\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:29:23Z","timestamp":1747114163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1540960\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":24,"alternative-id":["10.3389\/fmed.2025.1540960"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1540960","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"article-number":"1540960"}}